Intellectual Property India Publishes Patent Application for Design, Synthesis, Structural Characterization And Multi-Target Pharmacological Evaluation Of Quinoline–piperazine Hybrid Derivatives For Simultaneous Inhibition Of Monoamine Oxidase-B And Modulation Of Dopamine D2 Receptors For Neurovascular Disorders

MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202641069635 A) filed by Varikalla Rajashakar; Shraddha Shukla; Jyothirmai Namathoti; Dr. Maninder Pal Singh; Dr. Abhinav Anand; Dr. Rishab Bhanot; Dr. Narinderjit Kaur; Krishana Kumar Sharma; Shivam Sharma; and Ratna Ramchandra Chavan on June 03, 2026, for Design, Synthesis, Structural Characterization And Multi-Target Pharmacological Evaluation Of Quinoline–piperazine Hybrid Derivatives For Simultaneous Inhibition Of Monoamine Oxidase-B And Modulation Of Dopamine D2 Receptors For Neurovascular Disorders.

Inventors include Varikalla Rajashakar; Shraddha Shukla; Jyothirmai Namathoti; Dr. Maninder Pal Singh; Dr. Abhinav Anand; Dr. Rishab Bhanot; Dr. Na...